{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:36:13Z","timestamp":1792802173819,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12969-016-0112-6","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T07:51:02Z","timestamp":1473753062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases"],"prefix":"10.1186","volume":"14","author":[{"given":"Fabian","family":"Speth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9247-4729","authenticated-orcid":false,"given":"Claas H.","family":"Hinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"issue":"9631","key":"112_CR1","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371(9631):2201\u201312.","journal-title":"Lancet"},{"issue":"1","key":"112_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","volume":"62","author":"A Ravelli","year":"2010","unstructured":"Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res. 2010;62(1):63\u201372.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"112_CR3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr.22142","volume":"66","author":"AB Robinson","year":"2014","unstructured":"Robinson AB, Hoeltzel MF, Wahezi DM, Becker ML, Kessler EA, Schmeling H, et al. Clinical characteristics of children with juvenile dermatomyositis: the childhood arthritis and rheumatology research alliance registry. Arthritis Care Res. 2014;66(3):404\u201310.","journal-title":"Arthritis Care Res"},{"issue":"7","key":"112_CR4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00393-006-0109-5","volume":"65","author":"F Dressler","year":"2006","unstructured":"Dressler F, Huppertz HI. Juvenile dermatomyositis. Z Rheumatol. 2006;65(7):587\u201390. 92\u20134.","journal-title":"Z Rheumatol"},{"issue":"4","key":"112_CR5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","volume":"64","author":"AM Huber","year":"2012","unstructured":"Huber AM, Robinson AB, Reed AM, Abramson L, Bout-Tabaku S, Carrasco R, et al. Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. results of the second childhood arthritis and rheumatology research alliance consensus conference. Arthritis Care Res. 2012;64(4):546\u201353.","journal-title":"Arthritis Care Res"},{"issue":"11","key":"112_CR6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","volume":"7","author":"AB Robinson","year":"2011","unstructured":"Robinson AB, Reed AM. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol. 2011;7(11):664\u201375.","journal-title":"Nat Rev Rheumatol"},{"issue":"10019","key":"112_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","volume":"387","author":"N Ruperto","year":"2016","unstructured":"Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet. 2016;387(10019):671\u20138.","journal-title":"Lancet"},{"issue":"12","key":"112_CR8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1136\/ard.2011.153718","volume":"70","author":"CG Lam","year":"2011","unstructured":"Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM. Efficacy of intravenous Ig therapy in juvenile dermatomyositis. Ann Rheum Dis. 2011;70(12):2089\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"112_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","volume":"72","author":"A Sansome","year":"1995","unstructured":"Sansome A, Dubowitz V. Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases. Arch Dis Child. 1995;72(1):25\u20138.","journal-title":"Arch Dis Child"},{"issue":"21","key":"112_CR10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","volume":"367","author":"EW Gelfand","year":"2012","unstructured":"Gelfand EW. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med. 2012;367(21):2015\u201325.","journal-title":"N Engl J Med"},{"issue":"3","key":"112_CR11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","volume":"27","author":"VS Negi","year":"2007","unstructured":"Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007;27(3):233\u201345.","journal-title":"J Clin Immunol"},{"issue":"3","key":"112_CR12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tmrv.2013.05.004","volume":"27","author":"ER Stiehm","year":"2013","unstructured":"Stiehm ER. Adverse effects of human immunoglobulin therapy. Transfus Med Rev. 2013;27(3):171\u20138.","journal-title":"Transfus Med Rev"},{"issue":"4","key":"112_CR13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaci.2012.06.021","volume":"130","author":"RL Wasserman","year":"2012","unstructured":"Wasserman RL, Melamed I, Stein MR, Gupta S, Puck J, Engl W, et al. Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. J Allergy Clin Immunol. 2012;130(4):951\u20137. e11.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"112_CR14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10067-013-2478-x","volume":"33","author":"MG Danieli","year":"2014","unstructured":"Danieli MG, Moretti R, Gambini S, Paolini L, Gabrielli A. Open-label study on treatment with 20\u00a0% subcutaneous IgG administration in polymyositis and dermatomyositis. Clin Rheumatol. 2014;33(4):531\u20136.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"112_CR15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","volume":"10","author":"MG Danieli","year":"2011","unstructured":"Danieli MG, Pettinari L, Moretti R, Logullo F, Gabrielli A. Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. Autoimmun Rev. 2011;10(3):144\u20139.","journal-title":"Autoimmun Rev"},{"key":"112_CR16","doi-asserted-by":"crossref","unstructured":"de Inocencio J, Enr\u00edquez-Merayo E, Casado R, et al. Subcutaneous Immunoglobulin in Refractory Juvenile Dermatomyositis. Pediatrics. 2016;137(4):e20153537.","DOI":"10.1542\/peds.2015-3537"},{"issue":"3","key":"112_CR17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/cei.12694","volume":"182","author":"M Ponsford","year":"2015","unstructured":"Ponsford M, Carne E, Kingdon C, Joyce C, Price C, Williams C, et al. Facilitated subcutaneous immunoglobulin (fSCIg) therapy--practical considerations. Clin Exp Immunol. 2015;182(3):302\u201313.","journal-title":"Clin Exp Immunol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-016-0112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:39:47Z","timestamp":1498329587000},"score":1,"resource":{"primary":{"URL":"http:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-016-0112-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1186\/s12969-016-0112-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]},"article-number":"52"}}